Treating disorders accoiated with IL-20 receptor-mediated signaling pathway by blocking IL-20 receptor Activity

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

用阻抑IL-20受体活性的物?治?与IL-20受体介?的信?通路相?的病症(例如,骨?疏松症、?衰竭或糖尿病?病),所述物?例如通??合IL-20R1中和IL-20受体的抗体、抑制IL-20R1表?的反?核酸、抑制IL-20受体活性的小分子、或者IL-19、IL-20或IL-24的?性?突?体。
Original languageEnglish
Patent numberCN103052403B
Publication statusPublished - 1800

Cite this

@misc{ef4a285fade740338f2660f65317db6e,
title = "Treating disorders accoiated with IL-20 receptor-mediated signaling pathway by blocking IL-20 receptor Activity",
abstract = "用阻抑IL-20受体活性的物?治?与IL-20受体介?的信?通路相?的病症(例如,骨?疏松症、?衰竭或糖尿病?病),所述物?例如通??合IL-20R1中和IL-20受体的抗体、抑制IL-20R1表?的反?核酸、抑制IL-20受体活性的小分子、或者IL-19、IL-20或IL-24的?性?突?体。",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "CN103052403B",

}

TY - PAT

T1 - Treating disorders accoiated with IL-20 receptor-mediated signaling pathway by blocking IL-20 receptor Activity

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - 用阻抑IL-20受体活性的物?治?与IL-20受体介?的信?通路相?的病症(例如,骨?疏松症、?衰竭或糖尿病?病),所述物?例如通??合IL-20R1中和IL-20受体的抗体、抑制IL-20R1表?的反?核酸、抑制IL-20受体活性的小分子、或者IL-19、IL-20或IL-24的?性?突?体。

AB - 用阻抑IL-20受体活性的物?治?与IL-20受体介?的信?通路相?的病症(例如,骨?疏松症、?衰竭或糖尿病?病),所述物?例如通??合IL-20R1中和IL-20受体的抗体、抑制IL-20R1表?的反?核酸、抑制IL-20受体活性的小分子、或者IL-19、IL-20或IL-24的?性?突?体。

M3 - Patent

M1 - CN103052403B

ER -